Correlation Between Biodexa Pharmaceticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Eliem Therapeutics, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Eliem Therapeutics.
Diversification Opportunities for Biodexa Pharmaceticals and Eliem Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biodexa and Eliem is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Biodexa Pharmaceticals and Eliem Therapeutics
Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to generate 1.5 times more return on investment than Eliem Therapeutics. However, Biodexa Pharmaceticals is 1.5 times more volatile than Eliem Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 651.00 in Biodexa Pharmaceticals on August 29, 2024 and sell it today you would lose (171.00) from holding Biodexa Pharmaceticals or give up 26.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Biodexa Pharmaceticals vs. Eliem Therapeutics
Performance |
| Timeline |
| Biodexa Pharmaceticals |
| Eliem Therapeutics |
Biodexa Pharmaceticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biodexa Pharmaceticals and Eliem Therapeutics
The main advantage of trading using opposite Biodexa Pharmaceticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Biodexa Pharmaceticals vs. Eliem Therapeutics | Biodexa Pharmaceticals vs. Scpharmaceuticals | Biodexa Pharmaceticals vs. Milestone Pharmaceuticals | Biodexa Pharmaceticals vs. Seres Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |